In addition to wild type (WT) ERα, PHB2 can bind to ERα mutants, such as D538G and Y537S, which are often present in breast cancers that are resistant to hormonal therapy (Chigira et al., 2015). The gene discussed is PHB2; the disease is breast carcinoma.